AGM/EGMApr 27, 2026, 04:48 PM
QNCX Sets Annual Meeting for June 11; Proposes Reverse Stock Split
AI Summary
Quince Therapeutics, Inc. (QNCX) announced its 2026 Annual Meeting of Stockholders will be held virtually on Thursday, June 11, 2026. Key proposals include the election of a Class I director, approval of an amendment to effect a reverse stock split ranging from 1-for-10 to 1-for-100, ratification of BDO USA, P.C. as the independent auditor, and an advisory vote on executive compensation. Stockholders of record as of April 23, 2026, are eligible to vote.
Key Highlights
- QNCX to hold Annual Meeting of Stockholders virtually on June 11, 2026, at 10:00 a.m. Pacific Time.
- Stockholders to vote on electing a Class I director to serve until the 2029 annual meeting.
- Proposal to approve a reverse stock split of 1-for-10 to 1-for-100, at Board's discretion.
- Ratification of BDO USA, P.C. as independent registered public accounting firm for 2026.
- Advisory vote on the compensation of named executive officers.
- Stockholders of record as of April 23, 2026, are eligible to vote.
- Proxy materials available at https://www.astproxyportal.com/ast/22818/.
- Board recommends voting FOR all proposals.
Price Impact
More from QNCX